Search Results - "Salazar, Andres M."
-
1
Poly-ICLC, a multi-functional immune modulator for treating cancer
Published in Seminars in immunology (01-06-2020)“…•Poly-ICLC a synthetic dsRNA mimic stimulates both TLR3 and MDA5.•Poly-ICLC is a potent IFN-I and IL-15 inducer through MDA5 stimulation.•Poly-ICLC is a strong…”
Get full text
Journal Article -
2
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Published in Nature (London) (03-07-2014)“…Active tuberculosis has been linked to excessive type I interferon induction whereas interleukin-1 may have protective effects; here it is shown that…”
Get full text
Journal Article -
3
Phase I trial of overlapping long peptides from a tumor self-antigen and poly-ICLC shows rapid induction of integrated immune response in ovarian cancer patients
Published in Clinical cancer research (01-12-2012)“…Long peptides are efficiently presented to both CD4(+) and CD8(+) T cells after intracellular processing by antigen-presenting cells. To investigate the safety…”
Get full text
Journal Article -
4
Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Published in Journal of clinical oncology (20-01-2011)“…Purpose A phase I/II trial was performed to evaluate the safety and immunogenicity of a novel vaccination with α-type 1 polarized dendritic cells (αDC1) loaded…”
Get full text
Journal Article -
5
The route of administration dictates the immunogenicity of peptide-based cancer vaccines in mice
Published in Cancer Immunology, Immunotherapy (01-03-2019)“…Vaccines consisting of synthetic peptides representing cytotoxic T-lymphocyte (CTL) epitopes have long been considered as a simple and cost-effective approach…”
Get full text
Journal Article -
6
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4
Published in Proceedings of the National Academy of Sciences - PNAS (27-11-2018)“…Parainfluenza virus types 1–4 (PIV1–4) are highly infectious human pathogens, of which PIV3 is most commonly responsible for severe respiratory illness in…”
Get full text
Journal Article -
7
Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans
Published in The Journal of experimental medicine (21-11-2011)“…Adjuvants are critical for the success of vaccines. Agonists of microbial pattern recognition receptors (PRRs) are promising new adjuvant candidates. A…”
Get full text
Journal Article -
8
Adjuvants and the vaccine response to the DS-Cav1-stabilized fusion glycoprotein of respiratory syncytial virus
Published in PloS one (26-10-2017)“…Appropriate adjuvant selection may be essential to optimize the potency and to tailor the immune response of subunit vaccines. To induce protective responses…”
Get full text
Journal Article -
9
Poly-ICLC, a TLR3 Agonist, Induces Transient Innate Immune Responses in Patients With Treated HIV-Infection: A Randomized Double-Blinded Placebo Controlled Trial
Published in Frontiers in immunology (09-04-2019)“…Toll-like receptor-3 agonist Poly-ICLC has been known to activate immune cells and induce HIV replication in pre-clinical experiments. In this study we…”
Get full text
Journal Article -
10
Intranasal Poly-IC treatment exacerbates tuberculosis in mice through the pulmonary recruitment of a pathogen-permissive monocyte/macrophage population
Published in The Journal of clinical investigation (01-05-2010)“…Type I IFN has been demonstrated to have major regulatory effects on the outcome of bacterial infections. To assess the effects of exogenously induced type I…”
Get full text
Journal Article -
11
Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
Published in Journal of hematology and oncology (07-04-2017)“…Dendritic cells (DCs) enhance the quality of anti-tumor immune response in patients with cancer. Thus, we posit that DC-based immunotherapy, in conjunction…”
Get full text
Journal Article -
12
Long-term morbidities following self-reported mild traumatic brain injury
Published in Journal of clinical and experimental neuropsychology (06-08-2007)“…The objective of this study was to examine the prevalence of long-term psychiatric, neurologic, and psychosocial morbidities of self-reported mild traumatic…”
Get full text
Journal Article -
13
Antibodies targeting Clec9A promote strong humoral immunity without adjuvant in mice and non‐human primates
Published in European journal of immunology (01-03-2015)“…Targeting antigens to dendritic cell (DC) surface receptors using antibodies has been successfully used to generate strong immune responses and is currently in…”
Get full text
Journal Article -
14
Poly-IC enhances the effectiveness of cancer immunotherapy by promoting T cell tumor infiltration
Published in Journal for immunotherapy of cancer (21-09-2020)“…BackgroundImmunotherapies, such as immune checkpoint inhibitors and adoptive cell therapies, have revolutionized cancer treatment and resulted in complete and…”
Get full text
Journal Article -
15
Designing therapeutic cancer vaccines by mimicking viral infections
Published in Cancer Immunology, Immunotherapy (01-02-2017)“…The design of efficacious and cost-effective therapeutic vaccines against cancer remains both a research priority and a challenge. For more than a decade, our…”
Get full text
Journal Article Book Review -
16
Hiltonol Cocktail Kills Lung Cancer Cells by Activating Cancer-Suppressors, PKR/OAS, and Restraining the Tumor Microenvironment
Published in International journal of molecular sciences (05-02-2021)“…NSCLC (non-small cell lung cancer) is a leading cause of cancer-related deaths worldwide. Clinical trials showed that Hiltonol, a stable dsRNA representing an…”
Get full text
Journal Article -
17
Profound impairment of adaptive immune responses by alkylating chemotherapy
Published in The Journal of immunology (1950) (15-06-2013)“…Overall, cancer vaccines have had a record of failure as an adjuvant therapy for malignancies that are treated with alkylating chemotherapy, and the…”
Get full text
Journal Article -
18
Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates
Published in Proceedings of the National Academy of Sciences - PNAS (26-04-2011)“…Protein vaccines, if rendered immunogenic, would facilitate vaccine development against HIV and other pathogens. We compared in nonhuman primates (NHPs) immune…”
Get full text
Journal Article -
19
Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I·C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4+ T Cell Immunity and Protection in Mice
Published in Infection and Immunity (01-03-2013)“…Classifications Services IAI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text
Journal Article -
20
Type I IFN Induction via Poly-ICLC Protects Mice against Cryptococcosis
Published in PLoS pathogens (01-08-2015)“…Cryptococcus neoformans is the most common cause of fungal meningoencephalitis in AIDS patients. Depletion of CD4 cells, such as occurs during advanced AIDS,…”
Get full text
Journal Article